HBIO
HARVARD BIOSCIENCE INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$7.95
−1.00%Forward multiples
Based on analyst estimates
- P/E forward
- 44.17x
- P/E 2026E
- —
- P/E 2027E
- 12.55x
- P/E 2028E
- —
- P/S forward
- 0.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.88x
- Price / sales
- 0.41x
- Price / cash flow
- 55.76x
Enterprise value
- Enterprise value
- $73.9M
- EV / sales
- 0.84x
- EV / EBITDA
- -78.69x
- EV / EBIT
- 71.95x
- Market cap
- $36.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026